244 related articles for article (PubMed ID: 26586147)
1. Formulation and evaluation of anti-rheumatic dexibuprofen transdermal patches: a quality-by-design approach.
Akhlaq M; Arshad MS; Mudassir AM; Hussain A; Kucuk I; Haj-Ahmad R; Rasekh M; Ahmad Z
J Drug Target; 2016 Aug; 24(7):603-12. PubMed ID: 26586147
[TBL] [Abstract][Full Text] [Related]
2. PREPARATION, IN VITRO AND IN VIVO CHARACTERIZATION OF HYDROPHOBIC PATCHES OF A HIGHLY WATER SOLUBLE DRUG FOR PROLONGED PLASMA HALF LIFE: EFFECT OF PERMEATION ENHANCERS.
Yaqoob A; Ahmad M; Mahmood A; Sarfraz RM
Acta Pol Pharm; 2016 Nov; 73(6):1639-1648. PubMed ID: 29634120
[TBL] [Abstract][Full Text] [Related]
3. Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride.
Akram MR; Ahmad M; Abrar A; Sarfraz RM; Mahmood A
Drug Des Devel Ther; 2018; 12():349-364. PubMed ID: 29503528
[TBL] [Abstract][Full Text] [Related]
4. Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation.
Saoji SD; Atram SC; Dhore PW; Deole PS; Raut NA; Dave VS
AAPS PharmSciTech; 2015 Dec; 16(6):1344-56. PubMed ID: 25922089
[TBL] [Abstract][Full Text] [Related]
5. Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system.
Shahid N; Siddique MI; Razzaq Z; Katas H; Waqas MK; Rahman KU
Drug Dev Ind Pharm; 2018 Dec; 44(12):2061-2070. PubMed ID: 30081679
[TBL] [Abstract][Full Text] [Related]
6. Formulation design and in vitro ex vivo evaluation of transdermal patches of Cinnarizine.
Yamsani VV; Mudulaghar MK; Afreen S; Wajid S; Ravula SK; Babelghaith SD
Pak J Pharm Sci; 2017 Nov; 30(6):2075-2083. PubMed ID: 29175776
[TBL] [Abstract][Full Text] [Related]
7. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S
Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361
[TBL] [Abstract][Full Text] [Related]
8. Formulation, in vitro, and in vivo evaluation of matrix-type transdermal patches containing olanzapine.
Aggarwal G; Dhawan S; Harikumar SL
Pharm Dev Technol; 2013; 18(4):916-25. PubMed ID: 21913873
[TBL] [Abstract][Full Text] [Related]
9. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt.
Arora P; Mukherjee B
J Pharm Sci; 2002 Sep; 91(9):2076-89. PubMed ID: 12210054
[TBL] [Abstract][Full Text] [Related]
10. Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition.
Ameen D; Michniak-Kohn B
Eur J Pharm Biopharm; 2019 Jun; 139():262-271. PubMed ID: 30981946
[TBL] [Abstract][Full Text] [Related]
11. Design and Evaluation of Transdermal Patches of Timolol Maleate.
Panchayya Hiremath SS; Reddy JJ; Jamakandi VG
Curr Drug Deliv; 2018; 15(5):658-663. PubMed ID: 28969565
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of transdermal patches of flurbiprofen with ethyl cellulose.
Idrees A; Rahman NU; Javaid Z; Kashif M; Aslam I; Abbas K; Hussain T
Acta Pol Pharm; 2014; 71(2):287-95. PubMed ID: 25272649
[TBL] [Abstract][Full Text] [Related]
13. Effect of hydrophilic and hydrophobic polymers on permeation of S-amlodipine besylate through intercalated polymeric transdermal matrix: 3(2) designing, optimization and characterization.
Rastogi V; Yadav P; Husain A; Verma A
Drug Dev Ind Pharm; 2019 Apr; 45(4):669-682. PubMed ID: 30633579
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle formulations as recrystallization inhibitors in transdermal patches.
Tahir MA; Ali ME; Lamprecht A
Int J Pharm; 2020 Feb; 575():118886. PubMed ID: 31790804
[TBL] [Abstract][Full Text] [Related]
15. EFFECT OF HYDROPHILIC AND HYDROPHOBIC POLYMER ON IN VITRO DISSOLUTION AND PERMEATION OF BISOPROLOL FUMARATE THROUGH TRANSDERMAL PATCH.
Shabbir M; Ali S; Raza M; Sharif A; Akhtar FM; Manan A; Fazli AR; Younas N; Manzoor I
Acta Pol Pharm; 2017 Jan; 74(1):187-197. PubMed ID: 29474775
[TBL] [Abstract][Full Text] [Related]
16. Development of carvedilol transdermal patches: evaluation of physicochemical, ex vivo and mechanical properties.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(6):391-401. PubMed ID: 19634343
[TBL] [Abstract][Full Text] [Related]
17. Design, Development, and Optimization of Dexibuprofen Microemulsion Based Transdermal Reservoir Patches for Controlled Drug Delivery.
Ali FR; Shoaib MH; Yousuf RI; Ali SA; Imtiaz MS; Bashir L; Naz S
Biomed Res Int; 2017; 2017():4654958. PubMed ID: 29090219
[TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of transdermal drug delivery system for curcumin as an anti-inflammatory drug.
Patel NA; Patel NJ; Patel RP
Drug Dev Ind Pharm; 2009 Feb; 35(2):234-42. PubMed ID: 18785045
[TBL] [Abstract][Full Text] [Related]
19. Fabrication, evaluation, and enhanced penetration of vinyl and cellulose-engineered transdermal patch of nifedipine using essential oil as penetration enhancer.
Das S; Das S; Bahadur S; Mukherjee M; Nandi G; Manna S
J Biomater Sci Polym Ed; 2024 Jun; 35(9):1400-1420. PubMed ID: 38502545
[TBL] [Abstract][Full Text] [Related]
20. Development of nitrendipine transdermal patches: in vitro and ex vivo characterization.
Gannu R; Vishnu YV; Kishan V; Rao YM
Curr Drug Deliv; 2007 Jan; 4(1):69-76. PubMed ID: 17269919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]